Taken together, these results revealed weaker metastasis ability and lower vascular invasion in the sh-DDX21 group and confirmed that DDX21-knockdown inhibited CRC metastasis and angiogenesis in vivo. This evidence concerns the gene DDX21 and colorectal carcinoma.